全球癌症幹細胞市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

預計到2032年，全球癌症幹細胞市場需求將從2023年的18.6億美元達到近53.5億美元的市場規模，2024-2032年研究期間的複合年成長率為12.43%。

癌症幹細胞是腫瘤內的一小部分細胞，能夠自我更新並分化成原始腫瘤中發現的各種細胞類型。它們具有與正常幹細胞相似的特徵，例如啟動和維持腫瘤生長、抵抗傳統癌症療法以及可能轉移到身體的其他部位。識別和靶向這些細胞對於癌症治療策略至關重要，因為它們的存在通常與腫瘤復發和治療抗藥性有關。了解它們在腫瘤微環境中的生物學和相互作用對於開發從根本上根除癌症的有效療法至關重要。

市場動態

癌症幹細胞（CSC）領域為推進癌症治療策略提供了一條有希望的途徑。 CSC 研究和治療的市場促進因素包括人們對 CSC 在癌症復發和傳統療法抗藥性中的作用的日益了解。隨著研究人員深入研究 CSC 的分子和遺傳特徵，他們越來越認知到它們作為更有效治療目標的潛力，可以專門消除腫瘤形成和轉移的根本原因。此外，隨著技術的進步和新療​​法的開發，癌症幹細胞研究的市場機會正在擴大。製藥公司和生物技術公司正在大力投資 CSC 標靶藥物的發現和開發，旨在利用癌症治療中針對癌症幹細胞的潛在益處。全球癌症盛行率的上升進一步凸顯了對能夠改善患者治療結果和存活率的創新治療方法的迫切需求。此外，學術界、研究機構和產業參與者之間的合作有助於將基礎 CSC 研究轉化為臨床應用。然而，有效的抗復發標靶療法的開發、監管障礙以及治療成本的顯著增加可能會阻礙預測期內的市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球癌症幹細胞市場的各個細分市場進行了包容性評估。癌症幹細胞產業的成長和趨勢為這項研究提供了整體方法。

市場區隔

癌症幹細胞市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

按作用方式

• 標靶癌幹細胞 (CSC)
• （

透過抗 CSC 治療（通路抑制劑（WNT 訊號通路、Hedgehog 訊號通路、Notch 訊號通路等）、基於表面標記的、免疫逃脫和靶向腫瘤微環境、基於奈米顆粒的療法等）、產品（細胞培養細胞分離細胞分析分子分析其他）

• 以幹細胞為基礎的癌症治療（自體SC移植、異體SC移植）

按癌症形式

• 乳癌
• 血癌
• 肺癌
• 腦癌
• 大腸直腸癌
• 胰腺癌
• 膀胱癌
• 肝癌
• 其他癌症

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲癌症幹細胞市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。癌症幹細胞市場的主要參與者包括 Thermo Fisher Scientific Inc.、AbbVie Inc.、Merck KGaA、Bionomics、Lonza、Stemline Therapeutics Inc.、Miltenyi Biotec、PromoCell GmbH、MacroGenics Inc.、OncoMedceuticals Inc.、FuPromoCell GmbH、MacroGenics Inc.、OncoMedceuticals Inc.、FuProificm Iineine Scientine，幹細胞技術公司。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

• 報告說明
  • 客觀的
  • 目標受眾
  • 獨特的銷售主張 (USP) 和產品
• 研究範圍
• 研究方法
  • 市場研究過程
  • 市場研究方法論

第 2 章：執行摘要

• 市場亮點
• 全球市場概況

第 3 章：癌症幹細胞 - 產業分析

• 簡介 - 市場動態
• 市場促進因素
• 市場限制
• 機會
• 產業動態
• 波特五力分析
• 市場吸引力分析
  • 以行動方式進行的市場吸引力分析
  • 抗CSC 治療藥物的市場吸引力分析（通路抑制劑（WNT 訊號通路、Hedgehog 訊號通路、Notch 訊號通路等）、基於表面標記的、免疫逃脫和靶向腫瘤微環境、基於奈米顆粒的療法等）、產品（細胞培養 細胞分離 細胞分析 分子分析 其他）
  • 按癌症形式進行的市場吸引力分析
  • 市場吸引力分析：按地區

第 4 章：價值鏈分析

• 價值鏈分析
• 原料分析
  • 原料清單
  • 原料廠商清單
  • 主要原物料價格走勢
• 潛在買家名單
• 行銷管道
  • 直效行銷
  • 間接行銷
  • 行銷通路發展趨勢

第 5 章：全球癌症幹細胞市場分析：依作用模式分類

• 依作用方式概述
• 依作用方式進行歷史及預測資料分析
• 標靶癌幹細胞 (CSC)
• （

第 6 章：全球癌症幹細胞市場分析：按抗 CSC 治療（通路抑制劑（WNT 訊號通路、Hedgehog 訊號通路、Notch 訊號通路等）、基於表面標記、免疫逃脫和標靶腫瘤微環境，基於奈米粒子療法、其他）、產品（細胞培養、細胞分離、細胞分析、分子分析、其他）

• 抗 CSC 治療概述（通路抑制劑（WNT 訊號通路、Hedgehog 訊號通路、Notch 訊號通路等）、基於表面標記的、免疫逃脫和靶向腫瘤微環境、基於奈米顆粒的療法等）、產品（細胞-培養細胞分離細胞分析分子分析其他）
• 抗 CSC 療法的歷史和預測數據分析（通路抑制劑（WNT 訊號通路、Hedgehog 訊號通路、Notch 訊號通路等）、基於表面標記的、免疫逃脫和靶向腫瘤微環境、基於奈米顆粒的療法等），產物（細胞培養、細胞分離、細胞分析、分子分析、其他）
• 以幹細胞為基礎的癌症治療（自體SC移植、異體SC移植）

第 7 章：全球癌症幹細胞市場分析：以癌症形式分類

• 按癌症形式概述
• 按癌症形式進行的歷史和預測數據分析
• 乳癌
• 血癌
• 肺癌
• 腦癌
• 大腸直腸癌
• 胰腺癌
• 膀胱癌
• 肝癌
• 其他癌症

第 8 章：全球癌症幹細胞市場分析：依地理位置

• 區域展望
• 介紹
• 北美銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 北美按細分市場銷售分析
  • 北美按國家銷售分析
  • 美國銷售分析
  • 加拿大銷售分析
  • 墨西哥銷售分析
• 歐洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 歐洲按細分市場銷售分析
  • 歐洲按國家銷售分析
  • 英國銷售分析
  • 法國銷售分析
  • 德國銷售分析
  • 義大利銷售分析
  • 俄羅斯銷售分析
  • 歐洲其他地區銷售分析
• 亞太地區銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 亞太地區按細分市場銷售分析
  • 亞太地區按國家銷售分析
  • 中國銷售分析
  • 印度銷售分析
  • 日本銷售分析
  • 韓國銷售分析
  • 澳洲銷售分析
  • 東南亞銷售分析
  • 亞太地區其他地區銷售分析
• 拉丁美洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 拉丁美洲按細分市場銷售分析
  • 拉丁美洲按國家銷售分析
  • 巴西銷售分析
  • 阿根廷銷售分析
  • 秘魯銷售分析
  • 智利銷售分析
  • 拉丁美洲其他地區銷售分析
• 中東和非洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 中東和非洲按細分市場銷售分析
  • 中東和非洲按國家銷售分析
  • 沙烏地阿拉伯銷售分析
  • 阿拉伯聯合大公國銷售分析
  • 以色列銷售分析
  • 南非銷售分析
  • 中東其他地區和非洲銷售分析

第 9 章：癌症幹細胞公司的競爭格局

• 癌症幹細胞市場競爭
• 夥伴關係/協作/協議
• 併購
• 新產品發布
• 其他發展

第 10 章：公司簡介

• 頂級公司市佔率分析
• 市場集中度
• Thermo Fisher Scientific Inc.
• 公司概況
• 公司收入
• 產品
• 最新動態
• AbbVie Inc.
• 公司概況
• 公司收入
• 產品
• 最新動態
• Merck KGaA
• 公司概況
• 公司收入
• 產品
• 最新動態
• Bionomics
• 公司概況
• 公司收入
• 產品
• 最新動態
• Lonza
• 公司概況
• 公司收入
• 產品
• 最新動態
• Stemline Therapeutics Inc.
• 公司概況
• 公司收入
• 產品
• 最新動態
• Miltenyi Biotec
• 公司概況
• 公司收入
• 產品
• 最新動態
• PromoCell GmbH
• 公司概況
• 公司收入
• 產品
• 最新動態
• MacroGenics Inc.
• 公司概況
• 公司收入
• 產品
• 最新動態
• OncoMed Pharmaceuticals Inc.
• 公司概況
• 公司收入
• 產品
• 最新動態
• Fujifilm Irvine Scientific
• 公司概況
• 公司收入
• 產品
• 最新動態
• Stemcell Technologies.
• 公司概況
• 公司收入
• 產品
• 最新動態
• Sino Biological Inc.
• 公司概況
• 公司收入
• 產品
• 最新動態
• Lineage Cell Therapeutics Inc.
• 公司概況
• 公司收入
• 產品
• 最新動態
• 公司概況
• 公司收入
• 產品
• 最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

The global demand for Cancer Stem Cell Market is presumed to reach the market size of nearly USD 5.35 Billion by 2032 from USD 1.86 Billion in 2023 with a CAGR of 12.43% under the study period 2024-2032.

Cancer stem cells are a small subset of cells within tumors capable of self-renewal and differentiation into various cell types found in the original tumor. They possess characteristics similar to normal stem cells, such as initiating and sustaining tumor growth, resisting conventional cancer therapies, and potentially metastasizing to other parts of the body. Identifying and targeting these cells is crucial in cancer treatment strategies, as their presence often correlates with tumor recurrence and treatment resistance. Understanding their biology and interactions within the tumor microenvironment is essential for developing effective therapies to eradicate cancer at its root.

MARKET DYNAMICS

The cancer stem cells (CSCs) field presents a promising avenue for advancing cancer treatment strategies. Market drivers for CSC research and therapies include the growing understanding of CSCs' role in cancer recurrence and resistance to traditional therapies. As researchers delve deeper into the molecular & genetic characteristics of CSCs, they increasingly recognize their potential as targets for more effective treatments that can specifically eradicate the root cause of tumor formation and metastasis. Moreover, the market opportunities in cancer stem cell research are expanding with advancements in technology and the development of novel therapeutics. Pharmaceutical companies & biotech firms are investing heavily in CSC-targeted drug discovery and development, aiming to capitalize on the potential benefits of targeting cancer stem cells in cancer therapy. The rising prevalence of cancer worldwide further underscores the urgent need for innovative treatment approaches that can improve patient outcomes and survival rates. Furthermore, collaborations between academia, research institutes, and industry players facilitate translating basic CSC research into clinical applications. However, the development of effective targeted therapies resistant to relapse, regulatory hurdles, and significantly increasing cost of therapy will likely hamper market growth during the forecast period.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Cancer Stem Cell. The growth and trends of Cancer Stem Cell industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Cancer Stem Cell market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Mode of Action

• Targeted Cancerous Stem Cells (CSCs)
• (

By Anti-CSC Therapeutics (Pathway Inhibitors (WNT Signaling Pathway, Hedgehog Signaling Pathway, Notch Signaling Pathway, Others), Surface Marker-based, Immuno-evasion & Targeting Tumor Microenvironment, Nanoparticle-based Therapies, Others), Products (Cell-Culturing Cell-Separation Cell Analysis Molecular Analysis Others)

• Stem Cell-based Cancer Therapy (Autologous SC Transplant, Allogeneic SC Transplant)

By Cancer Forms

• Breast cancer
• Blood cancer
• Lung cancer
• Brain cancer
• Colorectal cancer
• Pancreatic cancer
• Bladder cancer
• Liver cancer
• Others cancer

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cancer Stem Cell market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cancer Stem Cell market include Thermo Fisher Scientific Inc., AbbVie Inc., Merck KGaA, Bionomics, Lonza, Stemline Therapeutics Inc., Miltenyi Biotec, PromoCell GmbH, MacroGenics Inc., OncoMed Pharmaceuticals Inc., Fujifilm Irvine Scientific, Stemcell Technologies., Sino Biological Inc., Lineage Cell Therapeutics Inc., . This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. CANCER STEM CELL - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Mode of Action
  • 3.7.2 Market Attractiveness Analysis By Anti-CSC Therapeutics (Pathway Inhibitors (WNT Signaling Pathway, Hedgehog Signaling Pathway, Notch Signaling Pathway, Others), Surface Marker-based, Immuno-evasion & Targeting Tumor Microenvironment, Nanoparticle-based Therapies, Others), Products (Cell-Culturing Cell-Separation Cell Analysis Molecular Analysis Others)
  • 3.7.3 Market Attractiveness Analysis By Cancer Forms
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL CANCER STEM CELL MARKET ANALYSIS BY MODE OF ACTION

• 5.1. Overview By Mode of Action
• 5.2. Historical and Forecast Data Analysis By Mode of Action
• 5.3. Targeted Cancerous Stem Cells (CSCs) Historic and Forecast Sales By Regions
• 5.4. ( Historic and Forecast Sales By Regions

6. GLOBAL CANCER STEM CELL MARKET ANALYSIS BY ANTI-CSC THERAPEUTICS (PATHWAY INHIBITORS (WNT SIGNALING PATHWAY, HEDGEHOG SIGNALING PATHWAY, NOTCH SIGNALING PATHWAY, OTHERS), SURFACE MARKER-BASED, IMMUNO-EVASION & TARGETING TUMOR MICROENVIRONMENT, NANOPARTICLE-BASED THERAPIES, OTHERS), PRODUCTS (CELL-CULTURING CELL-SEPARATION CELL ANALYSIS MOLECULAR ANALYSIS OTHERS)

• 6.1. Overview By Anti-CSC Therapeutics (Pathway Inhibitors (WNT Signaling Pathway, Hedgehog Signaling Pathway, Notch Signaling Pathway, Others), Surface Marker-based, Immuno-evasion & Targeting Tumor Microenvironment, Nanoparticle-based Therapies, Others), Products (Cell-Culturing Cell-Separation Cell Analysis Molecular Analysis Others)
• 6.2. Historical and Forecast Data Analysis By Anti-CSC Therapeutics (Pathway Inhibitors (WNT Signaling Pathway, Hedgehog Signaling Pathway, Notch Signaling Pathway, Others), Surface Marker-based, Immuno-evasion & Targeting Tumor Microenvironment, Nanoparticle-based Therapies, Others), Products (Cell-Culturing Cell-Separation Cell Analysis Molecular Analysis Others)
• 6.3. Stem Cell-based Cancer Therapy (Autologous SC Transplant, Allogeneic SC Transplant) Historic and Forecast Sales By Regions

7. GLOBAL CANCER STEM CELL MARKET ANALYSIS BY CANCER FORMS

• 7.1. Overview By Cancer Forms
• 7.2. Historical and Forecast Data Analysis By Cancer Forms
• 7.3. Breast cancer Historic and Forecast Sales By Regions
• 7.4. Blood cancer Historic and Forecast Sales By Regions
• 7.5. Lung cancer Historic and Forecast Sales By Regions
• 7.6. Brain cancer Historic and Forecast Sales By Regions
• 7.7. Colorectal cancer Historic and Forecast Sales By Regions
• 7.8. Pancreatic cancer Historic and Forecast Sales By Regions
• 7.9. Bladder cancer Historic and Forecast Sales By Regions
• 7.10. Liver cancer Historic and Forecast Sales By Regions
• 7.11. Others cancer Historic and Forecast Sales By Regions

8. GLOBAL CANCER STEM CELL MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE CANCER STEM CELL COMPANIES

• 9.1. Cancer Stem Cell Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF CANCER STEM CELL INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Thermo Fisher Scientific Inc.
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. AbbVie Inc.
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Merck KGaA
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. Bionomics
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. Lonza
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments
• 10.8. Stemline Therapeutics Inc.
  • 10.8.1 Company Overview
  • 10.8.2 Company Revenue
  • 10.8.3 Products
  • 10.8.4 Recent Developments
• 10.9. Miltenyi Biotec
  • 10.9.1 Company Overview
  • 10.9.2 Company Revenue
  • 10.9.3 Products
  • 10.9.4 Recent Developments
• 10.10. PromoCell GmbH
  • 10.10.1 Company Overview
  • 10.10.2 Company Revenue
  • 10.10.3 Products
  • 10.10.4 Recent Developments
• 10.11. MacroGenics Inc.
  • 10.11.1 Company Overview
  • 10.11.2 Company Revenue
  • 10.11.3 Products
  • 10.11.4 Recent Developments
• 10.12. OncoMed Pharmaceuticals Inc.
  • 10.12.1 Company Overview
  • 10.12.2 Company Revenue
  • 10.12.3 Products
  • 10.12.4 Recent Developments
• 10.13. Fujifilm Irvine Scientific
  • 10.13.1 Company Overview
  • 10.13.2 Company Revenue
  • 10.13.3 Products
  • 10.13.4 Recent Developments
• 10.14. Stemcell Technologies.
  • 10.14.1 Company Overview
  • 10.14.2 Company Revenue
  • 10.14.3 Products
  • 10.14.4 Recent Developments
• 10.15. Sino Biological Inc.
  • 10.15.1 Company Overview
  • 10.15.2 Company Revenue
  • 10.15.3 Products
  • 10.15.4 Recent Developments
• 10.16. Lineage Cell Therapeutics Inc.
  • 10.16.1 Company Overview
  • 10.16.2 Company Revenue
  • 10.16.3 Products
  • 10.16.4 Recent Developments
• 10.17.
  • 10.17.1 Company Overview
  • 10.17.2 Company Revenue
  • 10.17.3 Products
  • 10.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Mode of Action (USD MN)
• Targeted Cancerous Stem Cells (CSCs) Market Sales By Geography (USD MN)
• ( Market Sales By Geography (USD MN)
• Analysis By Anti-CSC Therapeutics (Pathway Inhibitors (WNT Signaling Pathway, Hedgehog Signaling Pathway, Notch Signaling Pathway, Others), Surface Marker-based, Immuno-evasion & Targeting Tumor Microenvironment, Nanoparticle-based Therapies, Others), Products (Cell-Culturing Cell-Separation Cell Analysis Molecular Analysis Others) (USD MN)
• Stem Cell-based Cancer Therapy (Autologous SC Transplant, Allogeneic SC Transplant) Market Sales By Geography (USD MN)
• Analysis By Cancer Forms (USD MN)
• Breast cancer Market Sales By Geography (USD MN)
• Blood cancer Market Sales By Geography (USD MN)
• Lung cancer Market Sales By Geography (USD MN)
• Brain cancer Market Sales By Geography (USD MN)
• Colorectal cancer Market Sales By Geography (USD MN)
• Pancreatic cancer Market Sales By Geography (USD MN)
• Bladder cancer Market Sales By Geography (USD MN)
• Liver cancer Market Sales By Geography (USD MN)
• Others cancer Market Sales By Geography (USD MN)
• Global Cancer Stem Cell Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Cancer Stem Cell Report
• Market Research Process
• Market Research Methodology
• Global Cancer Stem Cell Market Size, By Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Mode of Action
• Market Attractiveness Analysis By Anti-CSC Therapeutics (Pathway Inhibitors (WNT Signaling Pathway, Hedgehog Signaling Pathway, Notch Signaling Pathway, Others), Surface Marker-based, Immuno-evasion & Targeting Tumor Microenvironment, Nanoparticle-based Therapies, Others), Products (Cell-Culturing Cell-Separation Cell Analysis Molecular Analysis Others)
• Market Attractiveness Analysis By Cancer Forms
• Market Attractiveness Analysis By Region
• Value Chain Analysis
• Global Market Analysis By Mode of Action (USD MN)
• Targeted Cancerous Stem Cells (CSCs) Market Sales By Geography (USD MN)
• ( Market Sales By Geography (USD MN)
• Global Market Analysis By Anti-CSC Therapeutics (Pathway Inhibitors (WNT Signaling Pathway, Hedgehog Signaling Pathway, Notch Signaling Pathway, Others), Surface Marker-based, Immuno-evasion & Targeting Tumor Microenvironment, Nanoparticle-based Therapies, Others), Products (Cell-Culturing Cell-Separation Cell Analysis Molecular Analysis Others) (USD MN)
• Stem Cell-based Cancer Therapy (Autologous SC Transplant, Allogeneic SC Transplant) Market Sales By Geography (USD MN)
• Global Market Analysis By Cancer Forms (USD MN)
• Breast cancer Market Sales By Geography (USD MN)
• Blood cancer Market Sales By Geography (USD MN)
• Lung cancer Market Sales By Geography (USD MN)
• Brain cancer Market Sales By Geography (USD MN)
• Colorectal cancer Market Sales By Geography (USD MN)
• Pancreatic cancer Market Sales By Geography (USD MN)
• Bladder cancer Market Sales By Geography (USD MN)
• Liver cancer Market Sales By Geography (USD MN)
• Others cancer Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.